Novel Triple-dose Tuberculosis Retreatment Regimen

Abroad (travel likely)RecruitingPHASE3

Conditions

Multidrug-resistant Tuberculosis · Pulmonary Tuberculosis · Tuberculosis · Resistance to Tuberculostatic Drugs

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Damien Foundation, Niamey, Niger
Contact: Study coordinator (Bassirou Souleymane) · bachirsoul@gmail.com · +227 94985157
Contact: Principal Investigator (Sani Kadri)

Study leads

Sani Kadri
Principal Investigator
Ministry of Health, Niger

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Training Protocol on the Natural History of Tuberculosis

Mycobacterium Infections · Tuberculosis, Multidrug-Resistant · Latent Tuberculosis

Abroad (travel likely)Recruiting

Bethesda, United States

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Tuberculosis · Multidrug Resistant Pulmonary Tuberculosis · Rifampicin-resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Wuhan, China · Changsha, China

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Tuberculosis · Multidrug Resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Paris, France

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Pulmonary Tuberculosis

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Fuzhou, China